Phase II study of brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Brilacidin (Primary) ; Brilacidin (Primary)
- Indications Ulcerative colitis; Ulcerative proctitis; Ulcerative proctosigmoiditis
- Focus Proof of concept; Therapeutic Use
- Sponsors Innovation Pharmaceuticals
- 13 Jul 2017 Results from this trial have been presented at the Drug Discovery & Therapy World Congress, according to an Innovation Pharmaceuticals media release.
- 13 Jul 2017 Results published in an Innovation Pharmaceuticals media release.
- 26 Jun 2017 According to an Innovation Pharmaceuticals media release, topline results across all cohorts will be presented at the Drug Discovery & Therapy World Congress in Boston July 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History